Select Page

Putting Trump's Treatment in Context

  By Erik Sass, TES Editor-in-Chief   On May 18, President Trump announced that he began taking a combination of hydroxychloroquine (HCQ), azithromycin, and zinc about 10 days prior. This was around the same time that multiple White House staffers were reported to...

Why was positive HCQ data removed from draft of BMJ paper?

  On May 14, the British Medical Journal published an article presenting the results of a multi-center trial of hydroxychloroquine (HCQ) in Chinese patients with COVID-19 in February. It concluded:   “Administration of hydroxychloroquine did not result in a...

Promising COVID-19 Treatment Faces Political Hurdles

  Hydroxychloroquine (HCQ) is part of recommended treatment for COVID-19 in modern healthcare systems around the world, and every day brings new evidence that appears to support this judgment call by overseas public health authorities. Sadly the U.S. is the only...

Partisan Food Fight Hobbles COVID-19 Treatment Research

  By Erik Sass, Editor-in-Chief   The U.S. debate over chloroquine (CQ) and hydroxychloroquine (HCQ) has become highly politicized. Ever since President Trump first mentioned the drugs on March 19 as a potential treatments for COVID-19, views of the issue have been...